Fig. 2From: Patient-reported outcomes before treatment for localized prostate cancer: are there differences among countries? Data from the True North Global RegistryEPIC-26 domain scores of patients who underwent ERBT. Differences across countries were statistically significant in the majority of EPIC-26 scores (p < 0.05), with the exception of urinary irritative/obstructive (p = 0.153). Legend: The upper and lower whiskers represent scores outside the middle 50%, but within 1.5 times the interquartile range above the upper quartile and below the lower quartile (Q1—1.5 * IQR or Q3 + 1.5 * IQR)Back to article page